14 Jul. 2010
WILMINGTON, N.C. (July 14, 2010) - PPD, Inc. (Nasdaq: PPDI) announced it has appointed Henrietta Ukwu, M.D., FACP, FRAPS, as senior vice president of global regulatory affairs. She will have global responsibility for regulatory services across all PPD lines of business and provide clinical vaccine expertise to advance the company's vaccines and biologics operations.
"Dr. Ukwu brings exceptional leadership, product development and global regulatory expertise to PPD, having held senior positions in the pharmaceutical industry for the past 18 years," said Christine Dingivan, M.D., chief medical officer of PPD. "She has a well-earned reputation for building strategic regulatory teams and leading initiatives to drive regulatory excellence, which will help PPD continue to deliver superior regulatory assessment and strategies for all stages of our clients' product development."
Dr. Ukwu most recently served as vice president of global regulatory affairs at Wyeth Pharmaceuticals, Inc., now Pfizer, Inc., where her leadership and responsibility spanned vaccines, biologics and pharmaceuticals and all major regions including the United States, Canada, Asia Pacific, Latin America, Europe, Middle East and Africa. During this six-year period, Dr. Ukwu's responsibilities included overseeing strategic global product development and registration plans, human subject protection for clinical and preclinical development, and ensuring rigorous global regulatory standards and successful registration of new drugs and biologics.
Prior to joining Wyeth Pharmaceuticals, Dr. Ukwu spent nearly 12 years with Merck & Co., Inc., where she was promoted to positions of increasing responsibility, including head of vaccine regulatory development, vice president of global regulatory affairs and global regulatory policy.
Since joining the pharmaceutical industry, Dr. Ukwu has overseen the successful original regulatory development, filings and approvals of 14 new products.
Dr. Ukwu earned her medical and surgical degrees from the University of Jos School of Medicine in Nigeria. She completed her residency in internal medicine at Baptist Hospital in Nashville, Tenn., and her fellowship in infectious diseases at Vanderbilt University in Nashville. She is a fellow of the American College of Physicians (FACP) and the Regulatory Affairs Professional Society (FRAPS) and is a professor at the Graduate School of Pharmacy at Temple University in Ambler, Pa.